Expected earnings - Telomir Pharmaceuticals Inc.
Source: US Earnings Reports
Telomir Pharmaceuticals Inc. (TELO) is expected to report $-0.07 for Q4 2025
Telomir Pharmaceuticals Inc.
NASDAQ: TELO
TELO Trading
3.23% G/L:
$1.28 Last:
32,440 Volume:
$1.22 Open:
TELO Latest News
February 17, 2026 09:35:00 am
BioMedNewsBreaks - Telomir Pharmaceuticals (NASDAQ: TELO) Reports Iron-Dependent Tumor Cell Mortality in TNBC Models
February 17, 2026 08:00:00 am
Telomir Pharmaceuticals Demonstrates Broad Tumor Cell Mortality in Human Triple-Negative Breast Cancer Models
TELO Stock Data
$40,225,736
20,889,878
N/A
14
N/A
Biotechnology & Life Sciences
Healthcare
US
Miami
